

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | endothelium development (GO:0003158) | 9.81831981 |
| 2 | lymphangiogenesis (GO:0001946) | 7.24107915 |
| 3 | blood vessel maturation (GO:0001955) | 6.58723967 |
| 4 | positive regulation of vasculogenesis (GO:2001214) | 5.44218272 |
| 5 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 5.37575491 |
| 6 | angiogenesis involved in wound healing (GO:0060055) | 5.33707388 |
| 7 | vascular endothelial growth factor signaling pathway (GO:0038084) | 5.24159578 |
| 8 | regulation of vasculogenesis (GO:2001212) | 4.78720948 |
| 9 | lymph vessel development (GO:0001945) | 4.67162664 |
| 10 | sprouting angiogenesis (GO:0002040) | 4.53243012 |
| 11 | regulation of endothelial cell differentiation (GO:0045601) | 4.50926086 |
| 12 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 4.42769431 |
| 13 | morphogenesis of an endothelium (GO:0003159) | 4.28542553 |
| 14 | endothelial tube morphogenesis (GO:0061154) | 4.28542553 |
| 15 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 4.27130447 |
| 16 | glomerular filtration (GO:0003094) | 4.02628136 |
| 17 | endothelial cell proliferation (GO:0001935) | 3.76104626 |
| 18 | regulation of sarcomere organization (GO:0060297) | 3.75841966 |
| 19 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 3.69595801 |
| 20 | endothelial cell differentiation (GO:0045446) | 3.66572988 |
| 21 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.61201705 |
| 22 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 3.55600907 |
| 23 | regulation of sequestering of triglyceride (GO:0010889) | 3.54845931 |
| 24 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.47113497 |
| 25 | negative regulation of endothelial cell migration (GO:0010596) | 3.44367311 |
| 26 | renal filtration (GO:0097205) | 3.41282409 |
| 27 | transcytosis (GO:0045056) | 3.36991503 |
| 28 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 3.35568932 |
| 29 | atrial cardiac muscle cell action potential (GO:0086014) | 3.30071429 |
| 30 | negative regulation of protein autophosphorylation (GO:0031953) | 3.15922552 |
| 31 | artery development (GO:0060840) | 3.11968975 |
| 32 | ovulation from ovarian follicle (GO:0001542) | 3.00287146 |
| 33 | nephron epithelium development (GO:0072009) | 2.94471858 |
| 34 | Notch signaling involved in heart development (GO:0061314) | 2.89291902 |
| 35 | patterning of blood vessels (GO:0001569) | 2.87507916 |
| 36 | positive regulation of protein kinase C signaling (GO:0090037) | 2.84967498 |
| 37 | heart valve formation (GO:0003188) | 2.84839752 |
| 38 | positive regulation of glomerulus development (GO:0090193) | 2.84443930 |
| 39 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.83420962 |
| 40 | arginine catabolic process (GO:0006527) | 2.75991521 |
| 41 | cAMP biosynthetic process (GO:0006171) | 2.72985534 |
| 42 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.72542767 |
| 43 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.64803357 |
| 44 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.64306046 |
| 45 | regulation of blood vessel endothelial cell migration (GO:0043535) | 2.60730195 |
| 46 | negative regulation of angiogenesis (GO:0016525) | 2.60205156 |
| 47 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.58523362 |
| 48 | negative regulation of epithelial cell migration (GO:0010633) | 2.56396553 |
| 49 | wound healing, spreading of epidermal cells (GO:0035313) | 2.55698937 |
| 50 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.55524817 |
| 51 | negative regulation of blood vessel morphogenesis (GO:2000181) | 2.54063569 |
| 52 | regulation of establishment of cell polarity (GO:2000114) | 2.53927122 |
| 53 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.52386347 |
| 54 | negative regulation of DNA biosynthetic process (GO:2000279) | 2.52109884 |
| 55 | triglyceride catabolic process (GO:0019433) | 2.51411593 |
| 56 | embryonic heart tube development (GO:0035050) | 2.47594965 |
| 57 | heparin biosynthetic process (GO:0030210) | 2.46388586 |
| 58 | heparin metabolic process (GO:0030202) | 2.46388586 |
| 59 | thrombin receptor signaling pathway (GO:0070493) | 2.45841576 |
| 60 | regulation of endothelial cell migration (GO:0010594) | 2.45735322 |
| 61 | negative regulation of platelet activation (GO:0010544) | 2.45719146 |
| 62 | regulation of vascular permeability (GO:0043114) | 2.45497390 |
| 63 | positive regulation of urine volume (GO:0035810) | 2.45356024 |
| 64 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 2.44945239 |
| 65 | angiogenesis (GO:0001525) | 2.43939327 |
| 66 | negative regulation of vasculature development (GO:1901343) | 2.42494799 |
| 67 | phospholipid homeostasis (GO:0055091) | 2.42269424 |
| 68 | regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947) | 2.42101881 |
| 69 | regulation of skeletal muscle contraction (GO:0014819) | 2.37723287 |
| 70 | positive regulation of focal adhesion assembly (GO:0051894) | 2.36957993 |
| 71 | positive regulation of cell junction assembly (GO:1901890) | 2.36957993 |
| 72 | definitive hemopoiesis (GO:0060216) | 2.36770272 |
| 73 | vasculogenesis (GO:0001570) | 2.35413016 |
| 74 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.32392545 |
| 75 | heart trabecula formation (GO:0060347) | 2.32129945 |
| 76 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.31515902 |
| 77 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.29948495 |
| 78 | protein K11-linked deubiquitination (GO:0035871) | 2.29425196 |
| 79 | myofibril assembly (GO:0030239) | 2.27840958 |
| 80 | growth hormone receptor signaling pathway (GO:0060396) | 2.27122210 |
| 81 | cAMP metabolic process (GO:0046058) | 2.26552932 |
| 82 | regulation of lipoprotein metabolic process (GO:0050746) | 2.23914166 |
| 83 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.23471128 |
| 84 | negative regulation of focal adhesion assembly (GO:0051895) | 2.21932481 |
| 85 | negative regulation of cell junction assembly (GO:1901889) | 2.21932481 |
| 86 | negative regulation of adherens junction organization (GO:1903392) | 2.21932481 |
| 87 | neuron remodeling (GO:0016322) | 2.20764408 |
| 88 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.20426955 |
| 89 | L-fucose catabolic process (GO:0042355) | 2.20297133 |
| 90 | fucose catabolic process (GO:0019317) | 2.20297133 |
| 91 | L-fucose metabolic process (GO:0042354) | 2.20297133 |
| 92 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 2.19539297 |
| 93 | tachykinin receptor signaling pathway (GO:0007217) | 2.19007701 |
| 94 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.18293190 |
| 95 | regulation of synapse maturation (GO:0090128) | 2.17692934 |
| 96 | heart trabecula morphogenesis (GO:0061384) | 2.16607903 |
| 97 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.16570238 |
| 98 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.16408175 |
| 99 | signal peptide processing (GO:0006465) | 2.16214775 |
| 100 | regulation of cell-substrate junction assembly (GO:0090109) | 2.14887266 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.06307354 |
| 2 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.86585732 |
| 3 | VDR_22108803_ChIP-Seq_LS180_Human | 2.73198903 |
| 4 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.68906672 |
| 5 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.44765398 |
| 6 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.27226596 |
| 7 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.18437609 |
| 8 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.17463615 |
| 9 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.98906737 |
| 10 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.91465265 |
| 11 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.88100176 |
| 12 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.81703241 |
| 13 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.81096453 |
| 14 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.79971548 |
| 15 | P300_19829295_ChIP-Seq_ESCs_Human | 1.74546647 |
| 16 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.72751767 |
| 17 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.62552731 |
| 18 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.61231931 |
| 19 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.59265765 |
| 20 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.57659550 |
| 21 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.57011448 |
| 22 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.56742404 |
| 23 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.55439553 |
| 24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.55035643 |
| 25 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.51981273 |
| 26 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.51587086 |
| 27 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.51306333 |
| 28 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.47332566 |
| 29 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.46309928 |
| 30 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.45723922 |
| 31 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.45676487 |
| 32 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.44966413 |
| 33 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.43262003 |
| 34 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.41121392 |
| 35 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.40455684 |
| 36 | CJUN_26792858_Chip-Seq_BT549_Human | 1.40299469 |
| 37 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.39958347 |
| 38 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.39354107 |
| 39 | STAT3_23295773_ChIP-Seq_U87_Human | 1.38431014 |
| 40 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.38087134 |
| 41 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.36241219 |
| 42 | AR_25329375_ChIP-Seq_VCAP_Human | 1.35547482 |
| 43 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.34261364 |
| 44 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32469390 |
| 45 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.31906593 |
| 46 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.30162642 |
| 47 | TCF4_23295773_ChIP-Seq_U87_Human | 1.28062659 |
| 48 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.26838440 |
| 49 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.26326892 |
| 50 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23207621 |
| 51 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.19336592 |
| 52 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.17361970 |
| 53 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.17271856 |
| 54 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.17015999 |
| 55 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.16886242 |
| 56 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.15750425 |
| 57 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.15037588 |
| 58 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.15037588 |
| 59 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.14195578 |
| 60 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.13927359 |
| 61 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.13927359 |
| 62 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.12958288 |
| 63 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.12958288 |
| 64 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.12052637 |
| 65 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.11774995 |
| 66 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.10946987 |
| 67 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10813403 |
| 68 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.10590811 |
| 69 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09874179 |
| 70 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.09198625 |
| 71 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.09050634 |
| 72 | RXR_22108803_ChIP-Seq_LS180_Human | 1.08921589 |
| 73 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.08539422 |
| 74 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.08308319 |
| 75 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.07218993 |
| 76 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.06549458 |
| 77 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.05568523 |
| 78 | FUS_26573619_Chip-Seq_HEK293_Human | 1.05510602 |
| 79 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.04727703 |
| 80 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.03706187 |
| 81 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.03702005 |
| 82 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03358695 |
| 83 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.02702547 |
| 84 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.02702547 |
| 85 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.02223127 |
| 86 | * EWS_26573619_Chip-Seq_HEK293_Human | 1.01294055 |
| 87 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.00907701 |
| 88 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.99956680 |
| 89 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.99843007 |
| 90 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.99672153 |
| 91 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.98200172 |
| 92 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.98159806 |
| 93 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.97624113 |
| 94 | KDM2B_26808549_Chip-Seq_REH_Human | 0.97602223 |
| 95 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.97144276 |
| 96 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.96795266 |
| 97 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.96446269 |
| 98 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96343655 |
| 99 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.96312048 |
| 100 | TP53_16413492_ChIP-PET_HCT116_Human | 0.95346965 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010368_abnormal_lymphatic_system | 7.82278119 |
| 2 | MP0001879_abnormal_lymphatic_vessel | 5.86366658 |
| 3 | MP0005167_abnormal_blood-brain_barrier | 5.37352710 |
| 4 | MP0005670_abnormal_white_adipose | 3.31058965 |
| 5 | MP0006054_spinal_hemorrhage | 3.30023002 |
| 6 | MP0002138_abnormal_hepatobiliary_system | 2.96254597 |
| 7 | MP0003724_increased_susceptibility_to | 2.91534900 |
| 8 | MP0004272_abnormal_basement_membrane | 2.88691952 |
| 9 | MP0004084_abnormal_cardiac_muscle | 2.61194069 |
| 10 | MP0006138_congestive_heart_failure | 2.48224494 |
| 11 | MP0004145_abnormal_muscle_electrophysio | 2.37786947 |
| 12 | MP0004215_abnormal_myocardial_fiber | 2.37208442 |
| 13 | MP0003828_pulmonary_edema | 2.35725231 |
| 14 | MP0003646_muscle_fatigue | 2.33896709 |
| 15 | MP0004484_altered_response_of | 2.17447468 |
| 16 | MP0003195_calcinosis | 2.16953082 |
| 17 | MP0000013_abnormal_adipose_tissue | 2.16390201 |
| 18 | MP0000465_gastrointestinal_hemorrhage | 2.06100416 |
| 19 | MP0004130_abnormal_muscle_cell | 2.04283878 |
| 20 | MP0000767_abnormal_smooth_muscle | 2.00941062 |
| 21 | MP0005595_abnormal_vascular_smooth | 1.94155424 |
| 22 | MP0004036_abnormal_muscle_relaxation | 1.89494744 |
| 23 | MP0003950_abnormal_plasma_membrane | 1.83389195 |
| 24 | MP0003279_aneurysm | 1.81479554 |
| 25 | MP0008775_abnormal_heart_ventricle | 1.59023230 |
| 26 | MP0002127_abnormal_cardiovascular_syste | 1.54703115 |
| 27 | MP0000751_myopathy | 1.51107776 |
| 28 | MP0005385_cardiovascular_system_phenoty | 1.50157299 |
| 29 | MP0001544_abnormal_cardiovascular_syste | 1.50157299 |
| 30 | MP0002933_joint_inflammation | 1.48716609 |
| 31 | MP0002332_abnormal_exercise_endurance | 1.47597452 |
| 32 | MP0004085_abnormal_heartbeat | 1.46951828 |
| 33 | MP0005165_increased_susceptibility_to | 1.46573245 |
| 34 | MP0005620_abnormal_muscle_contractility | 1.44116027 |
| 35 | MP0000003_abnormal_adipose_tissue | 1.38262151 |
| 36 | MP0000249_abnormal_blood_vessel | 1.38178604 |
| 37 | MP0002638_abnormal_pupillary_reflex | 1.37743816 |
| 38 | MP0003045_fibrosis | 1.37451948 |
| 39 | MP0002295_abnormal_pulmonary_circulatio | 1.35991631 |
| 40 | MP0002876_abnormal_thyroid_physiology | 1.33694328 |
| 41 | MP0002972_abnormal_cardiac_muscle | 1.29478638 |
| 42 | MP0005375_adipose_tissue_phenotype | 1.26895546 |
| 43 | MP0004885_abnormal_endolymph | 1.22151655 |
| 44 | MP0000749_muscle_degeneration | 1.21144052 |
| 45 | MP0006276_abnormal_autonomic_nervous | 1.20913724 |
| 46 | MP0003303_peritoneal_inflammation | 1.20291091 |
| 47 | MP0002837_dystrophic_cardiac_calcinosis | 1.18512320 |
| 48 | MP0002128_abnormal_blood_circulation | 1.17773355 |
| 49 | MP0000230_abnormal_systemic_arterial | 1.17416148 |
| 50 | MP0001501_abnormal_sleep_pattern | 1.16905019 |
| 51 | MP0004147_increased_porphyrin_level | 1.16560447 |
| 52 | MP0001614_abnormal_blood_vessel | 1.12917270 |
| 53 | MP0005551_abnormal_eye_electrophysiolog | 1.12720945 |
| 54 | MP0005084_abnormal_gallbladder_morpholo | 1.12254762 |
| 55 | MP0005330_cardiomyopathy | 1.02603555 |
| 56 | MP0002925_abnormal_cardiovascular_devel | 0.99603040 |
| 57 | MP0002108_abnormal_muscle_morphology | 0.98854715 |
| 58 | MP0002971_abnormal_brown_adipose | 0.98602670 |
| 59 | MP0005666_abnormal_adipose_tissue | 0.95722036 |
| 60 | MP0002106_abnormal_muscle_physiology | 0.95091433 |
| 61 | MP0002168_other_aberrant_phenotype | 0.93478970 |
| 62 | MP0003868_abnormal_feces_composition | 0.88248293 |
| 63 | MP0003137_abnormal_impulse_conducting | 0.87861526 |
| 64 | MP0005369_muscle_phenotype | 0.87737068 |
| 65 | MP0004782_abnormal_surfactant_physiolog | 0.87503591 |
| 66 | MP0010329_abnormal_lipoprotein_level | 0.86911895 |
| 67 | MP0004043_abnormal_pH_regulation | 0.85572532 |
| 68 | MP0005187_abnormal_penis_morphology | 0.78077850 |
| 69 | MP0003633_abnormal_nervous_system | 0.77044193 |
| 70 | MP0004087_abnormal_muscle_fiber | 0.75307317 |
| 71 | MP0009780_abnormal_chondrocyte_physiolo | 0.72471285 |
| 72 | MP0001486_abnormal_startle_reflex | 0.72137763 |
| 73 | MP0000266_abnormal_heart_morphology | 0.72005401 |
| 74 | MP0005253_abnormal_eye_physiology | 0.71916852 |
| 75 | MP0010630_abnormal_cardiac_muscle | 0.70828876 |
| 76 | MP0001784_abnormal_fluid_regulation | 0.70327128 |
| 77 | MP0003638_abnormal_response/metabolism_ | 0.67109498 |
| 78 | MP0009115_abnormal_fat_cell | 0.65145427 |
| 79 | MP0005275_abnormal_skin_tensile | 0.58544903 |
| 80 | MP0003943_abnormal_hepatobiliary_system | 0.57439785 |
| 81 | MP0005535_abnormal_body_temperature | 0.57141032 |
| 82 | MP0005409_darkened_coat_color | 0.56091128 |
| 83 | MP0005266_abnormal_metabolism | 0.53837117 |
| 84 | MP0005503_abnormal_tendon_morphology | 0.50785810 |
| 85 | MP0000343_altered_response_to | 0.50440849 |
| 86 | MP0000759_abnormal_skeletal_muscle | 0.49888748 |
| 87 | MP0009046_muscle_twitch | 0.49491170 |
| 88 | MP0001915_intracranial_hemorrhage | 0.49120039 |
| 89 | MP0001968_abnormal_touch/_nociception | 0.46631197 |
| 90 | MP0003959_abnormal_lean_body | 0.46500768 |
| 91 | MP0003948_abnormal_gas_homeostasis | 0.46274181 |
| 92 | MP0005448_abnormal_energy_balance | 0.45941287 |
| 93 | MP0002118_abnormal_lipid_homeostasis | 0.45354957 |
| 94 | MP0005334_abnormal_fat_pad | 0.44400356 |
| 95 | MP0002970_abnormal_white_adipose | 0.43215674 |
| 96 | MP0003631_nervous_system_phenotype | 0.42813915 |
| 97 | MP0005195_abnormal_posterior_eye | 0.41944915 |
| 98 | MP0001485_abnormal_pinna_reflex | 0.41383713 |
| 99 | MP0000372_irregular_coat_pigmentation | 0.40030670 |
| 100 | MP0009745_abnormal_behavioral_response | 0.40026564 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hematochezia (HP:0002573) | 5.18102411 |
| 2 | Muscle fiber splitting (HP:0003555) | 4.10713960 |
| 3 | Spontaneous hematomas (HP:0007420) | 3.74892230 |
| 4 | Cerebral hemorrhage (HP:0001342) | 3.69833537 |
| 5 | Lymphangioma (HP:0100764) | 3.67249098 |
| 6 | Adactyly (HP:0009776) | 3.54352764 |
| 7 | Portal hypertension (HP:0001409) | 3.51131590 |
| 8 | Nonimmune hydrops fetalis (HP:0001790) | 3.32371669 |
| 9 | Wrist flexion contracture (HP:0001239) | 3.29763585 |
| 10 | Esophageal varix (HP:0002040) | 3.28612895 |
| 11 | Difficulty running (HP:0009046) | 3.17346514 |
| 12 | Polycythemia (HP:0001901) | 3.15087679 |
| 13 | Hyporeflexia of lower limbs (HP:0002600) | 3.14181863 |
| 14 | Abnormality of the hepatic vasculature (HP:0006707) | 3.10822469 |
| 15 | Attenuation of retinal blood vessels (HP:0007843) | 3.00778064 |
| 16 | Atrial fibrillation (HP:0005110) | 3.00190184 |
| 17 | Heart block (HP:0012722) | 2.94722287 |
| 18 | Skull defect (HP:0001362) | 2.92067314 |
| 19 | Congenital stationary night blindness (HP:0007642) | 2.91591056 |
| 20 | Hyperventilation (HP:0002883) | 2.90977987 |
| 21 | Scotoma (HP:0000575) | 2.87486114 |
| 22 | Supraventricular arrhythmia (HP:0005115) | 2.84257060 |
| 23 | Myotonia (HP:0002486) | 2.82103254 |
| 24 | Pancreatic cysts (HP:0001737) | 2.77874539 |
| 25 | Primary atrial arrhythmia (HP:0001692) | 2.77348454 |
| 26 | Atrioventricular block (HP:0001678) | 2.77270602 |
| 27 | Decreased circulating renin level (HP:0003351) | 2.74131365 |
| 28 | Bulbous nose (HP:0000414) | 2.71696280 |
| 29 | Abnormal atrioventricular conduction (HP:0005150) | 2.62969469 |
| 30 | Keratoconus (HP:0000563) | 2.62944240 |
| 31 | Increased corneal curvature (HP:0100692) | 2.62944240 |
| 32 | Pigmentary retinal degeneration (HP:0001146) | 2.62617438 |
| 33 | Supraventricular tachycardia (HP:0004755) | 2.58480112 |
| 34 | Bundle branch block (HP:0011710) | 2.55625036 |
| 35 | Cerebral aneurysm (HP:0004944) | 2.52937599 |
| 36 | Calf muscle hypertrophy (HP:0008981) | 2.51897407 |
| 37 | Abnormality of macular pigmentation (HP:0008002) | 2.50027645 |
| 38 | Areflexia of lower limbs (HP:0002522) | 2.48515372 |
| 39 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.46865189 |
| 40 | Conjunctival telangiectasia (HP:0000524) | 2.46155141 |
| 41 | Muscle fiber inclusion bodies (HP:0100299) | 2.45864319 |
| 42 | Myocardial infarction (HP:0001658) | 2.45255902 |
| 43 | Hyperlipoproteinemia (HP:0010980) | 2.43947968 |
| 44 | Visceral angiomatosis (HP:0100761) | 2.41574165 |
| 45 | Facial diplegia (HP:0001349) | 2.40876028 |
| 46 | Nemaline bodies (HP:0003798) | 2.39623231 |
| 47 | Prolonged QT interval (HP:0001657) | 2.38313076 |
| 48 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.36113315 |
| 49 | Oligomenorrhea (HP:0000876) | 2.35247474 |
| 50 | Hemiplegia (HP:0002301) | 2.33227725 |
| 51 | Absent hand (HP:0004050) | 2.27088344 |
| 52 | Abnormality of the renal cortex (HP:0011035) | 2.24822303 |
| 53 | True hermaphroditism (HP:0010459) | 2.24691962 |
| 54 | Syncope (HP:0001279) | 2.21277980 |
| 55 | Central scotoma (HP:0000603) | 2.21226267 |
| 56 | Congenital sensorineural hearing impairment (HP:0008527) | 2.19721293 |
| 57 | Pancreatic fibrosis (HP:0100732) | 2.18826386 |
| 58 | Decreased central vision (HP:0007663) | 2.16630970 |
| 59 | Distal arthrogryposis (HP:0005684) | 2.16422539 |
| 60 | Hemiparesis (HP:0001269) | 2.14924236 |
| 61 | Hemangiomatosis (HP:0007461) | 2.14235164 |
| 62 | Congenital hepatic fibrosis (HP:0002612) | 2.13396207 |
| 63 | Aortic aneurysm (HP:0004942) | 2.13166498 |
| 64 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.13117266 |
| 65 | Abnormality of the calf musculature (HP:0001430) | 2.11926189 |
| 66 | Polydipsia (HP:0001959) | 2.10441668 |
| 67 | Abnormal drinking behavior (HP:0030082) | 2.10441668 |
| 68 | Inability to walk (HP:0002540) | 2.08601772 |
| 69 | Aortic valve stenosis (HP:0001650) | 2.08509666 |
| 70 | Abnormality of midbrain morphology (HP:0002418) | 2.06420333 |
| 71 | Molar tooth sign on MRI (HP:0002419) | 2.06420333 |
| 72 | Hip contracture (HP:0003273) | 2.05065213 |
| 73 | Sudden death (HP:0001699) | 2.03854118 |
| 74 | Hyperkalemia (HP:0002153) | 2.03549347 |
| 75 | Broad-based gait (HP:0002136) | 2.03536708 |
| 76 | Congenital, generalized hypertrichosis (HP:0004540) | 2.02849781 |
| 77 | Abnormality of the renal medulla (HP:0100957) | 2.02186435 |
| 78 | Exotropia (HP:0000577) | 2.01540454 |
| 79 | Occipital encephalocele (HP:0002085) | 2.01106348 |
| 80 | Increased variability in muscle fiber diameter (HP:0003557) | 2.00935641 |
| 81 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.97227031 |
| 82 | Delayed CNS myelination (HP:0002188) | 1.96473033 |
| 83 | Type 1 muscle fiber predominance (HP:0003803) | 1.94500514 |
| 84 | Nephronophthisis (HP:0000090) | 1.94372938 |
| 85 | Tubular atrophy (HP:0000092) | 1.94109579 |
| 86 | Cystic liver disease (HP:0006706) | 1.91695556 |
| 87 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.91509058 |
| 88 | EMG: myopathic abnormalities (HP:0003458) | 1.90996775 |
| 89 | Asymmetric septal hypertrophy (HP:0001670) | 1.89680960 |
| 90 | Prominent supraorbital ridges (HP:0000336) | 1.88782589 |
| 91 | Abnormality of the ischium (HP:0003174) | 1.88466418 |
| 92 | Type II lissencephaly (HP:0007260) | 1.87179068 |
| 93 | Abolished electroretinogram (ERG) (HP:0000550) | 1.84520138 |
| 94 | Febrile seizures (HP:0002373) | 1.82833719 |
| 95 | Porencephaly (HP:0002132) | 1.82513943 |
| 96 | Lipoatrophy (HP:0100578) | 1.81608878 |
| 97 | Chronic hepatic failure (HP:0100626) | 1.81249400 |
| 98 | Abnormal EKG (HP:0003115) | 1.79581924 |
| 99 | Large for gestational age (HP:0001520) | 1.78458726 |
| 100 | Arterial tortuosity (HP:0005116) | 1.78171352 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDR | 4.33991341 |
| 2 | FRK | 4.17069068 |
| 3 | TGFBR2 | 2.61577668 |
| 4 | FER | 2.52638773 |
| 5 | BMPR1B | 2.18731091 |
| 6 | TIE1 | 11.5063444 |
| 7 | GRK1 | 1.86709258 |
| 8 | TGFBR1 | 1.85338044 |
| 9 | EPHB2 | 1.82936044 |
| 10 | FES | 1.75150942 |
| 11 | OBSCN | 1.67613246 |
| 12 | TEC | 1.52866080 |
| 13 | PTK2B | 1.51540152 |
| 14 | INSRR | 1.34618153 |
| 15 | PINK1 | 1.27935153 |
| 16 | ACVR1B | 1.26486916 |
| 17 | MAPKAPK3 | 1.23141164 |
| 18 | MYLK | 1.18293908 |
| 19 | ADRBK2 | 1.15463695 |
| 20 | WNK3 | 1.15083259 |
| 21 | MAPK13 | 1.12141753 |
| 22 | PRKAA2 | 1.10478945 |
| 23 | PHKG2 | 0.96806023 |
| 24 | PHKG1 | 0.96806023 |
| 25 | EPHA3 | 0.95810385 |
| 26 | STK38L | 0.94238842 |
| 27 | TRPM7 | 0.91775237 |
| 28 | NLK | 0.90732000 |
| 29 | DAPK2 | 0.89994426 |
| 30 | MAP4K2 | 0.87218250 |
| 31 | NUAK1 | 0.84512957 |
| 32 | GRK5 | 0.78099267 |
| 33 | NTRK3 | 0.76360446 |
| 34 | ADRBK1 | 0.74817027 |
| 35 | STK39 | 0.72530333 |
| 36 | PIK3CG | 0.71807617 |
| 37 | MAP3K7 | 0.71117302 |
| 38 | PAK3 | 0.69936559 |
| 39 | LATS1 | 0.68326081 |
| 40 | MAPK12 | 0.62044688 |
| 41 | PRKG2 | 0.61445255 |
| 42 | PRKCE | 0.60785317 |
| 43 | RIPK1 | 0.60271194 |
| 44 | MAPKAPK5 | 0.58636165 |
| 45 | OXSR1 | 0.57432330 |
| 46 | TAOK3 | 0.57195104 |
| 47 | IRAK1 | 0.56730156 |
| 48 | PKN1 | 0.56674382 |
| 49 | KIT | 0.56102826 |
| 50 | CAMK1 | 0.54831664 |
| 51 | FLT3 | 0.54258605 |
| 52 | ROCK1 | 0.53632565 |
| 53 | PIK3CA | 0.52970506 |
| 54 | PRKD1 | 0.51559520 |
| 55 | IGF1R | 0.46451744 |
| 56 | CSK | 0.45342469 |
| 57 | TTN | 0.42662943 |
| 58 | TXK | 0.41695470 |
| 59 | PRKAA1 | 0.41293448 |
| 60 | MARK1 | 0.41165467 |
| 61 | CAMK2A | 0.40730250 |
| 62 | STK38 | 0.40061210 |
| 63 | MAPK15 | 0.39076722 |
| 64 | FGFR2 | 0.38855064 |
| 65 | EPHB1 | 0.37797304 |
| 66 | PRKD3 | 0.37723476 |
| 67 | ITK | 0.37423735 |
| 68 | SGK2 | 0.35983510 |
| 69 | MAPK7 | 0.34898116 |
| 70 | PRKG1 | 0.33734802 |
| 71 | PDK2 | 0.32366001 |
| 72 | MET | 0.30222365 |
| 73 | PTK2 | 0.30203102 |
| 74 | MAP2K1 | 0.29900493 |
| 75 | CASK | 0.29774107 |
| 76 | TNIK | 0.28604659 |
| 77 | CSNK1G1 | 0.27618412 |
| 78 | AKT3 | 0.25506247 |
| 79 | MAPK4 | 0.25256782 |
| 80 | EEF2K | 0.25000362 |
| 81 | ZAP70 | 0.23641761 |
| 82 | PLK2 | 0.22912156 |
| 83 | MKNK2 | 0.22560640 |
| 84 | PRKACA | 0.22410058 |
| 85 | TNK2 | 0.22275024 |
| 86 | HCK | 0.21935993 |
| 87 | CDC42BPA | 0.21284150 |
| 88 | CAMK4 | 0.21146649 |
| 89 | STK11 | 0.20968004 |
| 90 | EGFR | 0.20543098 |
| 91 | NTRK1 | 0.20465022 |
| 92 | BCR | 0.20430002 |
| 93 | PDGFRB | 0.20255225 |
| 94 | GSK3A | 0.19694405 |
| 95 | MAP2K6 | 0.19002488 |
| 96 | MUSK | 0.18141510 |
| 97 | ABL1 | 0.16511265 |
| 98 | CAMKK2 | 0.16487763 |
| 99 | ZAK | 0.16043182 |
| 100 | ROCK2 | 0.15772757 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.28596901 |
| 2 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.11831694 |
| 3 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.11134703 |
| 4 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.98686242 |
| 5 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.95343439 |
| 6 | ABC transporters_Homo sapiens_hsa02010 | 1.94415701 |
| 7 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.93452626 |
| 8 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.92845103 |
| 9 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.89201892 |
| 10 | Phototransduction_Homo sapiens_hsa04744 | 1.85916704 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.80246530 |
| 12 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.76510118 |
| 13 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.76272056 |
| 14 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.74477628 |
| 15 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.67481699 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.61712580 |
| 17 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.61068490 |
| 18 | Morphine addiction_Homo sapiens_hsa05032 | 1.56031619 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.55916986 |
| 20 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.51621340 |
| 21 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.50109793 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.48201526 |
| 23 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.47236572 |
| 24 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.45342729 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.40732163 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.40406687 |
| 27 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.34152236 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.26897918 |
| 29 | Circadian entrainment_Homo sapiens_hsa04713 | 1.26605770 |
| 30 | Focal adhesion_Homo sapiens_hsa04510 | 1.25398183 |
| 31 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.24482605 |
| 32 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.24252800 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.24124579 |
| 34 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.23132432 |
| 35 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.21649578 |
| 36 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.21505693 |
| 37 | Salivary secretion_Homo sapiens_hsa04970 | 1.16988298 |
| 38 | Ras signaling pathway_Homo sapiens_hsa04014 | 1.11735356 |
| 39 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.10874261 |
| 40 | Taste transduction_Homo sapiens_hsa04742 | 1.06326446 |
| 41 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.06098755 |
| 42 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.05239226 |
| 43 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.05237494 |
| 44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.04495405 |
| 45 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.03312475 |
| 46 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.03134145 |
| 47 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.03045926 |
| 48 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.99448843 |
| 49 | Platelet activation_Homo sapiens_hsa04611 | 0.97752559 |
| 50 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.97502016 |
| 51 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.96253626 |
| 52 | GABAergic synapse_Homo sapiens_hsa04727 | 0.96207440 |
| 53 | Insulin secretion_Homo sapiens_hsa04911 | 0.96020568 |
| 54 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.95778571 |
| 55 | Nicotine addiction_Homo sapiens_hsa05033 | 0.94380483 |
| 56 | Circadian rhythm_Homo sapiens_hsa04710 | 0.93485328 |
| 57 | Olfactory transduction_Homo sapiens_hsa04740 | 0.93201693 |
| 58 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.91915234 |
| 59 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.91791989 |
| 60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.89258800 |
| 61 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.88705966 |
| 62 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.87942071 |
| 63 | Tight junction_Homo sapiens_hsa04530 | 0.87852341 |
| 64 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.87204038 |
| 65 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.86719016 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79578476 |
| 67 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.78952178 |
| 68 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.78854678 |
| 69 | Axon guidance_Homo sapiens_hsa04360 | 0.78437531 |
| 70 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.78258778 |
| 71 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.74968272 |
| 72 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.72462360 |
| 73 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.71136671 |
| 74 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.70657090 |
| 75 | Retinol metabolism_Homo sapiens_hsa00830 | 0.70017667 |
| 76 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.69698001 |
| 77 | Bile secretion_Homo sapiens_hsa04976 | 0.68115714 |
| 78 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.67608883 |
| 79 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.65177075 |
| 80 | Peroxisome_Homo sapiens_hsa04146 | 0.64839686 |
| 81 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.64094018 |
| 82 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.62778810 |
| 83 | Adherens junction_Homo sapiens_hsa04520 | 0.60704991 |
| 84 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.60471829 |
| 85 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.60351802 |
| 86 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.60049027 |
| 87 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.59877279 |
| 88 | Lysine degradation_Homo sapiens_hsa00310 | 0.56398148 |
| 89 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.53975189 |
| 90 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.52489609 |
| 91 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.50472940 |
| 92 | Long-term depression_Homo sapiens_hsa04730 | 0.48993252 |
| 93 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.47049387 |
| 94 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.45967857 |
| 95 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.44873713 |
| 96 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.44256871 |
| 97 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.44033984 |
| 98 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.43726932 |
| 99 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.43386179 |
| 100 | Insulin resistance_Homo sapiens_hsa04931 | 0.41218805 |

